818 related articles for article (PubMed ID: 22973869)
21. Caval tumor thrombus volume influences outcomes in renal cell carcinoma with venous extension.
Zargar-Shoshtari K; Sharma P; Espiritu P; Kurian T; Pow-Sang JM; Mangar D; Sexton WJ; Spiess PE
Urol Oncol; 2015 Mar; 33(3):112.e23-9. PubMed ID: 25555854
[TBL] [Abstract][Full Text] [Related]
22. Surgical strategy for treating renal cell carcinoma with thrombus extending into the inferior vena cava.
Jibiki M; Iwai T; Inoue Y; Sugano N; Kihara K; Hyochi N; Sunamori M
J Vasc Surg; 2004 Apr; 39(4):829-35. PubMed ID: 15071451
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of venous tumour thrombus consistency in patients with renal cell carcinoma (RCC).
Weiss VL; Braun M; Perner S; Harz A; Vorreuther R; Kristiansen G; Müller SC; Ellinger J
BJU Int; 2014 Feb; 113(2):209-17. PubMed ID: 24053185
[TBL] [Abstract][Full Text] [Related]
24. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup.
Haferkamp A; Bastian PJ; Jakobi H; Pritsch M; Pfitzenmaier J; Albers P; Hallscheidt P; Müller SC; Hohenfellner M
J Urol; 2007 May; 177(5):1703-8. PubMed ID: 17437789
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors of renal cell carcinoma with extension into inferior vena cava.
Tanaka M; Fujimoto K; Okajima E; Tanaka N; Yoshida K; Hirao Y
Int J Urol; 2008 May; 15(5):394-8. PubMed ID: 18452454
[TBL] [Abstract][Full Text] [Related]
26. Laparoscopic Radical Nephrectomy and Inferior Vena Cava Thrombectomy in the Treatment of Renal Cell Carcinoma.
Shao P; Li J; Qin C; Lv Q; Ju X; Li P; Shao Y; Ni B; Yin C
Eur Urol; 2015 Jul; 68(1):115-22. PubMed ID: 25534934
[TBL] [Abstract][Full Text] [Related]
27. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus.
Lambert EH; Pierorazio PM; Shabsigh A; Olsson CA; Benson MC; McKiernan JM
Urology; 2007 Jun; 69(6):1054-8. PubMed ID: 17572185
[TBL] [Abstract][Full Text] [Related]
28. Pathobiology and prognosis of chromophobe renal cell carcinoma.
Klatte T; Han KR; Said JW; Böhm M; Allhoff EP; Kabbinavar FF; Belldegrun AS; Pantuck AJ
Urol Oncol; 2008; 26(6):604-9. PubMed ID: 18367104
[TBL] [Abstract][Full Text] [Related]
29. Inferior vena cava involvement in renal cell carcinoma: comparison of survival rates between patients with thrombus and infiltration.
Zugor V; Labanaris AP; Lausen B; Schott GE
Scand J Urol Nephrol; 2008; 42(1):35-9. PubMed ID: 18210335
[TBL] [Abstract][Full Text] [Related]
30. The Cleveland Clinic experience with papillary (chromophil) renal cell carcinoma: clinical outcome with histopathological correlation.
Chow GK; Myles J; Novick AC
Can J Urol; 2001 Apr; 8(2):1223-8. PubMed ID: 11375785
[TBL] [Abstract][Full Text] [Related]
31. [Study of the prognostic value of DNA ploidy and proliferation index (Ki-67) in renal cell carcinoma with venous thrombus].
Rey D; Pfister C; Gobet F; Martinez S; Staerman F; Grise P
Prog Urol; 2003 Dec; 13(6):1300-6. PubMed ID: 15000303
[TBL] [Abstract][Full Text] [Related]
32. Chromophobe renal cell carcinoma in Iceland: an epidemiological and clinicopathological study.
Ingimarsson JP; Hardarson S; Petursdottir V; Jonsson E; Einarsson GV; Gudbjartsson T
Scand J Urol Nephrol; 2011 Nov; 45(5):306-11. PubMed ID: 21619417
[TBL] [Abstract][Full Text] [Related]
33. Oncologic outcomes following surgical resection of renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter cohort.
Haddad AQ; Wood CG; Abel EJ; Krabbe LM; Darwish OM; Thompson RH; Heckman JE; Merril MM; Gayed BA; Sagalowsky AI; Boorjian SA; Margulis V; Leibovich BC
J Urol; 2014 Oct; 192(4):1050-6. PubMed ID: 24704115
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of tumour multifocality in renal cell carcinoma.
Siracusano S; Novara G; Antonelli A; Artibani W; Bertini R; Carini M; Carmignani G; Ciciliato S; Cunico SC; Lampropoulou N; Longo N; Martorana G; Minervini A; Mirone V; Simeone C; Simonato A; Valotto C; Zattoni F; Ficarra V;
BJU Int; 2012 Dec; 110(11 Pt B):E443-8. PubMed ID: 22502873
[TBL] [Abstract][Full Text] [Related]
35. Endoluminal occlusion of the inferior vena cava in renal cell carcinoma with retro- or suprahepatic caval thrombus.
Zini L; Haulon S; Leroy X; Christophe D; Koussa M; Biserte J; Villers A
BJU Int; 2006 Jun; 97(6):1216-20. PubMed ID: 16686714
[TBL] [Abstract][Full Text] [Related]
36. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
37. Cytohistopathologic hybrid renal cell carcinoma with papillary and clear cell features.
Mai KT; Kohler DM; Roustan Delatour NL; Veinot JP
Pathol Res Pract; 2006; 202(12):863-8. PubMed ID: 17034957
[TBL] [Abstract][Full Text] [Related]
38. A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumor.
Mai KT; Landry DC; Robertson SJ; Commons AS; Burns BF; Thijssen A; Collins J
Pathol Res Pract; 2001; 197(10):671-5. PubMed ID: 11700888
[TBL] [Abstract][Full Text] [Related]
39. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
[TBL] [Abstract][Full Text] [Related]
40. Long-term survival in patients undergoing radical nephrectomy and inferior vena cava thrombectomy: single-center experience.
Ciancio G; Manoharan M; Katkoori D; De Los Santos R; Soloway MS
Eur Urol; 2010 Apr; 57(4):667-72. PubMed ID: 19560258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
